neoadjuvant ipi nivo in stage iii melanoma: updates from opacin & opacin-neo
Published 3 years ago • 53 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:52
opacin-neo trial rfs and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma
-
1:39
opacin and opacin-neo: neoadjuvant immunotherapy for advanced melanoma
-
1:54
opacin-neo and prado: personalized neoadjuvant io for melanoma based on pathologic response
-
1:36
nadina trial: neoadjuvant ipilimumab nivolumab vs. adjuvant nivolumab in stage iii melanoma
-
1:22
the personalization of neoadjuvant immunotherapy in stage iii melanoma
-
2:46
neoadjuvant therapy in bulky stage iii melanoma
-
0:57
circulating immune cell subsets in patients with melanoma from the opacin-neo trial
-
1:55
neoadjuvant ipilimumab plus nivolumab in stage iii melanoma
-
1:48
dr. blank on the opacin, opacin-neo trials in stage iii macroscopic melanoma
-
1:20
neopele: neoadjuvant pembrolizumab and lenvatinib in resectable stage iii melanoma
-
2:53
opacin-neo: tmb and ifn-γ identified as biomarkers of pathologic response in melanoma
-
3:15
optimal neoadjuvant io in resectable stage iii melanoma: interferon gamma signature analysis
-
1:12
investigators present updated results of the opacin trial for melanoma
-
27:18
adjuvant and neoadjuvant dilemmas
-
2:43
tumor characteristics of patients with recurrence after neoadjuvant ipi nivo in melanoma
-
2:12
omitting total lymph node dissection and adjuvant therapy in melanoma
-
2:48
nadina trial: neoadjuvant ipilimumab nivolumab shows superior efs in resectable stage iii melanoma
-
3:44
neoadjuvant approaches in melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma